2022
DOI: 10.1002/alz.12587
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes

Abstract: Introduction: Identification of novel therapeutics and risk assessment in early stages of Alzheimer's disease (AD) is a crucial aspect of addressing this complex disease. We characterized gene-expression patterns at the mild cognitive impairment (MCI) stage to identify critical mRNA measures and gene clusters associated with AD pathogenesis. Methods:We used a transcriptomics approach, integrating magnetic resonance imaging (MRI) and peripheral blood-based gene expression data using persistent homology (PH) fol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…Western blot was conducted as described previously with some modifications . First, the protein of brain tissue was extracted using a mixture of lysis solution and protease inhibitor.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Western blot was conducted as described previously with some modifications . First, the protein of brain tissue was extracted using a mixture of lysis solution and protease inhibitor.…”
Section: Methodsmentioning
confidence: 99%
“…Western blot was conducted as described previously with some modifications. 34 First, the protein of brain tissue was extracted using a mixture of lysis solution and protease inhibitor. Next, total protein lysates were separated on 5× SDS-PAGE and electro-blotted onto PVDF membrane, immersed in 5% nonfat milk, sealed for 1.5 h, then cleaned four times with TBST buffer solution.…”
Section: Real-time Polymerase Chain Reaction (Qrt-pcr) and Western Blotmentioning
confidence: 99%